A citation-based method for searching scientific literature

Massimo Santoro, Francesca Carlomagno. Cold Spring Harb Perspect Biol 2013
Times Cited: 67



Cristina Romei, Raffaele Ciampi, Rossella Elisei. Nat Rev Endocrinol 2016
Times Cited: 163




List of shared articles



Times cited

Multi-gene assay and clinical characteristics research in papillary thyroid carcinoma.
Chang Deng, Shan Li, Zhixin Yang, Yi Dou, Daixing Hu, Jiang Zhu, Denghui Wang, Xinliang Su. Gland Surg 2021
3

Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.
Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett. J Med Chem 2021
1

RET kinase inhibitors for RET-altered thyroid cancers.
Danica M Vodopivec, Mimi I Hu. Ther Adv Med Oncol 2022
0

Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases.
Marialuisa Moccia, Donglin Yang, Naga Rajiv Lakkaniga, Brendan Frett, Nicholas McConnell, Lingtian Zhang, Annalisa Brescia, Giorgia Federico, Lingzhi Zhang, Paolo Salerno,[...]. Sci Rep 2021
0

Current status of biomarker testing in historically rare, high-unmet-need tumors: soft tissue sarcomas and thyroid cancers.
Bridgette Schroader, Sheldon Kong, Sibyl Anderson, Todd Williamson, Anthony Sireci, Kasia Shields. Expert Rev Anticancer Ther 2019
2

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.
Alexander Drilon, Zishuo I Hu, Gillianne G Y Lai, Daniel S W Tan. Nat Rev Clin Oncol 2018
137

Radiation-Induced Thyroid Cancers: Overview of Molecular Signatures.
Keiji Suzuki, Vladimir Saenko, Shunichi Yamashita, Norisato Mitsutake. Cancers (Basel) 2019
9

State-of-the-Art Strategies for Targeting RET-Dependent Cancers.
Vivek Subbiah, Dong Yang, Vamsidhar Velcheti, Alexander Drilon, Funda Meric-Bernstam. J Clin Oncol 2020
80


Animal models of medullary thyroid cancer: state of the art and view to the future.
Giovanni Vitale, Germano Gaudenzi, Luisa Circelli, Marco F Manzoni, Andrea Bassi, Niccolò Fioritti, Antongiulio Faggiano, Annamaria Colao. Endocr Relat Cancer 2017
20

Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions.
Mariantonia Nacchio, Pasquale Pisapia, Francesco Pepe, Gianluca Russo, Elena Vigliar, Tommaso Porcelli, Cristina Luongo, Antonino Iaccarino, Fabio Pagni, Domenico Salvatore,[...]. Expert Rev Endocrinol Metab 2022
0

Kinase gene fusions: roles and therapeutic value in progressive and refractory papillary thyroid cancer.
Mian Liu, Pei Chen, Hui-Yu Hu, Deng-Jie Ou-Yang, Rooh-Afza Khushbu, Hai-Long Tan, Peng Huang, Shi Chang. J Cancer Res Clin Oncol 2021
3

Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies.
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa. Cancer Treat Rev 2022
0


Ret receptor tyrosine kinase sustains proliferation and tissue maturation in intestinal epithelia.
Daniel Perea, Jordi Guiu, Bruno Hudry, Chrysoula Konstantinidou, Alexandra Milona, Dafni Hadjieconomou, Thomas Carroll, Nina Hoyer, Dipa Natarajan, Jukka Kallijärvi,[...]. EMBO J 2017
17

Influencers on Thyroid Cancer Onset: Molecular Genetic Basis.
Berta Luzón-Toro, Raquel María Fernández, Leticia Villalba-Benito, Ana Torroglosa, Guillermo Antiñolo, Salud Borrego. Genes (Basel) 2019
12

RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations.
Mosin S Khan, Qurteeba Qadri, Mudasir J Makhdoomi, Muneer A Wani, Aejaz A Malik, Madiha Niyaz, Shariq R Masoodi, Khurshid I Andrabi, Rauf Ahmad, Syed Mudassar. Pathol Oncol Res 2020
13